example 2 [WO2013004676]   Click here for help

GtoPdb Ligand ID: 7852

Synonyms: entry 2 [PMID: 24900681] [1]
Compound class: Synthetic organic
Comment: This compound is a BACE1 or BACE2 inhibitor, and is example 2 from patent WO2013004676 [2] (with 8 examples tested). Also published as patent review [1]. This is more potent against BACE2 even although the patent is focused on BACE1 for Alzheimer's disease (AD).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 105.67
Molecular weight 390.07
XLogP 2.95
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)C12N=C(N)SCCC2C1)F
Isomeric SMILES Clc1ccc(nc1)C(=O)Nc1ccc(c(c1)[C@]12N=C(N)SCC[C@@H]2C1)F
InChI InChI=1S/C18H16ClFN4OS/c19-11-1-4-15(22-9-11)16(25)23-12-2-3-14(20)13(7-12)18-8-10(18)5-6-26-17(21)24-18/h1-4,7,9-10H,5-6,8H2,(H2,21,24)(H,23,25)/t10-,18+/m1/s1
InChI Key COCAUCFPFHUGAA-MGNBDDOMSA-N
References
1. Blass B. (2013)
Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors.
ACS Med Chem Lett, 4 (4): 379-80. [PMID:24900681]
2. Woltering T. (2012)
Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors.
Patent number: WO2013004676. Assignee: Roche. Priority date: 06/07/2011. Publication date: 10/01/2012.